Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 1
2002 1
2004 1
2005 2
2006 2
2007 2
2008 3
2009 5
2010 4
2011 10
2012 6
2013 6
2014 3
2015 8
2016 5
2017 6
2018 6
2019 5
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Ekimov A, Arunachalam AB, Blake T, Bodle J, Couzens L, Dubey S, Eichelberger M, Engelhardt OG, Gubinelli F, Joshi M, Melnyk D, Palladino G, Rigsby P, Rockman S, Savina N, Smith E, Gilchrist SAN; World Health Organization's Pandemic Influenza preparedness, Vaccine Response's Alternative Potency, Reagents Technical Working Group. Ekimov A, et al. Among authors: eichelberger m. Vaccine. 2023 Jul 19;41(32):4639-4647. doi: 10.1016/j.vaccine.2023.06.051. Epub 2023 Jun 19. Vaccine. 2023. PMID: 37344260 Free article.
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang W, Alvarado-Facundo E, Vassell R, Collins L, Colombo RE, Ganesan A, Geaney C, Hrncir D, Lalani T, Markelz AE, Maves RC, McClenathan B, Mende K, Richard SA, Schofield C, Seshadri S, Spooner C, Utz GC, Warkentien TE, Levine M, Coles CL, Burgess TH, Eichelberger M, Weiss CD. Wang W, et al. Among authors: eichelberger m. Clin Infect Dis. 2021 Dec 6;73(11):e4312-e4320. doi: 10.1093/cid/ciaa1352. Clin Infect Dis. 2021. PMID: 32898271 Clinical Trial.
Peter's Paradigm and Pandemic Preparedness.
Eichelberger MC. Eichelberger MC. Viral Immunol. 2020 Apr;33(3):208-210. doi: 10.1089/vim.2019.0155. Viral Immunol. 2020. PMID: 32286173 Free PMC article. No abstract available.
Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits.
Weiss CD, Wang W, Lu Y, Billings M, Eick-Cost A, Couzens L, Sanchez JL, Hawksworth AW, Seguin P, Myers CA, Forshee R, Eichelberger MC, Cooper MJ. Weiss CD, et al. Among authors: eichelberger mc. Clin Infect Dis. 2020 Dec 15;71(12):3096-3102. doi: 10.1093/cid/ciz1198. Clin Infect Dis. 2020. PMID: 31840159 Free PMC article.
Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F, Palladino L, Manenti A, Stanzani V, Lapini G, Gao J, Couzens L, Eichelberger MC, Montomoli E. Biuso F, et al. Among authors: eichelberger mc. Influenza Other Respir Viruses. 2019 Sep;13(5):504-516. doi: 10.1111/irv.12669. Influenza Other Respir Viruses. 2019. PMID: 31411006 Free PMC article.
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
Wan H, Gao J, Yang H, Yang S, Harvey R, Chen YQ, Zheng NY, Chang J, Carney PJ, Li X, Plant E, Jiang L, Couzens L, Wang C, Strohmeier S, Wu WW, Shen RF, Krammer F, Cipollo JF, Wilson PC, Stevens J, Wan XF, Eichelberger MC, Ye Z. Wan H, et al. Among authors: eichelberger mc. Nat Microbiol. 2019 Dec;4(12):2216-2225. doi: 10.1038/s41564-019-0522-6. Epub 2019 Aug 12. Nat Microbiol. 2019. PMID: 31406333 Free PMC article.
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Gao J, Couzens L, Burke DF, Wan H, Wilson P, Memoli MJ, Xu X, Harvey R, Wrammert J, Ahmed R, Taubenberger JK, Smith DJ, Fouchier RAM, Eichelberger MC. Gao J, et al. Among authors: eichelberger mc. mBio. 2019 Apr 9;10(2):e00307-19. doi: 10.1128/mBio.00307-19. mBio. 2019. PMID: 30967460 Free PMC article.
Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
Petrie JG, Martin ET, Truscon R, Johnson E, Cheng CK, McSpadden EJ, Malosh RE, Lauring AS, Lamerato LE, Eichelberger MC, Ferdinands JM, Monto AS. Petrie JG, et al. Among authors: eichelberger mc. Vaccine. 2019 Feb 28;37(10):1284-1292. doi: 10.1016/j.vaccine.2019.01.055. Epub 2019 Feb 7. Vaccine. 2019. PMID: 30738647 Free PMC article.
77 results